Select Page

Extension of Early Access to Medicines Scheme for trial Pompe drug.

Avalglucosidase Alfa update

    Enrolment for avalglucosidase alfa under the Early Access to Medicines Scheme has been extended while the drug awaits regulatory approval.

    If this affects you or is of interest to you, please do contact your medical practitioner,